The Discounted Cash Flow (DCF) valuation of Apontis Pharma AG (APPH.DE) is 11.33 EUR. With the latest stock price at 11.00 EUR, the upside of Apontis Pharma AG based on DCF is 3.0%.
Based on the latest price of 11.00 EUR and our DCF valuation, Apontis Pharma AG (APPH.DE) is a buy. buying APPH.DE stocks now will result in a potential gain of 3.0%.
| Range | Selected | |
| WACC / Discount Rate | 5.0% - 6.4% | 5.7% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 6.60 - 46.28 | 11.33 |
| Upside | -40.0% - 320.7% | 3.0% |